BMRN earnings call for the period ending December 31, 2020.
News & Analysis: BioMarin Pharmaceutical
Shares in this biotech company are down considerably from where they were this summer, but the stock looks ready to take off again.
BMRN earnings call for the period ending September 30, 2020.
Patient investors could double their money in these two stocks that the market has temporarily cast aside.
The biotech managed to overcome headwinds caused by the COVID-19 pandemic.
Many of us want to forget this year, but investors in these three companies will be especially eager to put 2020 in the rearview mirror.
Even with a mild recovery for the markets, some stocks found themselves on the losing side.
Daily injections of vosoritide sped up growth rates for children with the most common form of dwarfism.
Getting new one-time treatments to patients who need them isn't getting any easier.
The Fed spoiled the party for the stock market.